Sunshine Biopharma (SBFM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2019 | 06-2019 | 03-2019 | 12-2018 | 09-2018 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 82 | 37 | 95 | 111 | 46 |
| Receivables | N/A | 1 | 119 | N/A | 103 |
| Inventories | 18 | 18 | 13 | N/A | N/A |
| Other current assets | 8 | 8 | 0 | 990 | 0 |
| TOTAL | $111 | $71 | $231 | $1,101 | $151 |
| Non-Current Assets | |||||
| PPE Net | 36 | 39 | 254 | 45 | 280 |
| Intangibles | 0 | 0 | 761 | 0 | 674 |
| TOTAL | $36 | $39 | $1,016 | $45 | $954 |
| Total Assets | $146 | $109 | $1,247 | $1,147 | $1,104 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 65 | 84 | 140 | 116 | 105 |
| Accrued Expenses | 45 | 35 | 19 | 684 | 30 |
| TOTAL | $889 | $926 | $1,120 | $913 | $747 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | N/A | 290 | 290 | 313 |
| TOTAL | $N/A | $N/A | $336 | $290 | $313 |
| Total Liabilities | $889 | $926 | $1,459 | $1,202 | $1,060 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 260 | 67 | 48 | 45 | 816 |
| Common Shares | 311 | 104 | 89 | 4 | 1,586 |
| Retained earnings | -17,038 | -16,688 | -15,977 | -15,774 | -15,436 |
| Other shareholders' equity | -2 | -2 | -5 | -4 | 4 |
| TOTAL | $-743 | $-816 | $-212 | $-56 | $45 |
| Total Liabilities And Equity | $146 | $109 | $1,247 | $1,147 | $1,104 |